Desloratadine | API DMFs | US Drug Master File (DMF) Details | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Desloratadine
USDMF

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Desloratadine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 16 USDMF, 13 CEP/COS, 23 EU WC, 3 KDMF, 11 NDC API, 36 Listed Suppliers, $ API Reference Price

55 API Suppliers
16 USDMF
13 CEP/COS
23 EU WC
3 KDMF
11 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

277 FDF Dossiers, 24 FDA Orange Book, 153 Europe, 5 Canada, 41 South Africa, 54 Listed Dossiers

277 FDF Dossiers
24 FDA Orange Book
153 Europe
5 Canada
41 South Africa
54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG, SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

TABLET;ORAL - 5MG
SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 3 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 3 DKSH, 7 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 45 Direct Compression, 35 Controlled & Modified Release, 34 Disintegrants & Superdisintegrants, 30 Granulation, 30 Taste Masking, 27 Thickeners and Stabilizers, 26 Lubricants & Glidants, 24 Film Formers & Plasticizers, 23 Solubilizers, 20 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 19 Parenteral, 16 Topical, 8 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

88 Fillers, Diluents & Binders
60 Coating Systems & Additives
45 Direct Compression
35 Controlled & Modified Release
34 Disintegrants & Superdisintegrants
30 Granulation
30 Taste Masking
27 Thickeners and Stabilizers
26 Lubricants & Glidants
24 Film Formers & Plasticizers
23 Solubilizers
20 Chewable & Orodispersible Aids
20 Co-Processed Excipients
19 Parenteral
16 Topical
8 Emulsifying Agents
8 API Stability Enhancers
5 Empty Capsules
4 Rheology Modifiers
4 Vegetarian Capsules
4 Coloring Agents
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 5 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 114 Finished Drug Prices, 6 Annual Reports

3 US Medicaid Prescriptions
114 Finished Drug Prices
6 Annual Reports

MARKET PLACE

27 APIs, 10 FDF Dossiers, 1 EXCIPIENTS

27 APIs
10 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 17 Others

2 EDQM
4 USP
17 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 912 Xls

Filters

Reset all filters

Filters

FILTER :

filter Holder Reset all filters

16 All

01 1Dr. Reddy's Laboratories

02 1TAPI Technology & API Services

03 1Cadila Pharmaceuticals

04 2Cipla

05 1Divis Laboratories

06 1Glenmark Life Sciences

07 1Hainan Poly Pharm

08 1Lupin Ltd

09 1Morepen Laboratories

10 1Orchid Pharma

11 1RANBAXY LABORATORIES LIMITED

12 1Sun Pharmaceutical Industries Limited

13 1Taro Pharmaceutical Industries

14 1Vasudha Pharma Chem

15 1Viatris

filter Subject Reset all filters

16 All

01 9DESLORATADINE

02 2DESLORATADINE DRUG SUBSTANCE

03 1DESLORATADINE FORM I: FORM II (89:11)

04 4DESLORATADINE USP

filter Country Reset all filters

16 All

01 1China

02 12India

03 1Israel

04 2U.S.A

filter Status Reset all filters

16 All

01 10Active

02 6Inactive

filter GDUFA DMF Review Reset all filters

16 All

01 3Complete

02 13Blank

List of Suppliers

Product Main Page

01

Dr Reddys Laboratories Ltd

CPhI WW Frankfurt

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

Digital Content

DESLORATADINE USP

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19456

Submission : 2006-05-24

Status : Active

Type : II

Dr Reddy Company Banner

Product Web Link

Digital Content

02

Teva Pharmaceutical Industries Ltd

TAPI offers customized CDMO Solutions for API development and manufacturing services.

Contact Supplier

Contact Supplier

Digital Content

DESLORATADINE DRUG SUBSTANCE

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19403

Submission : 2006-05-02

Status : Inactive

Type : II

TAPI Company Banner

Product Web Link

Digital Content

03

Cadila Pharmaceuticals Ltd

USDMF

PharmaVenue

Not Confirmed

03

Cadila Pharmaceuticals Ltd

PharmaVenue

Not Confirmed